| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 724783 | [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 | 0.00289834947687855 | -0.24624273 |
| NSC 716524 | Null | 0.00313644776247638 | 0.24741502 |
| NSC 205862 | Null | 0.00313644776247642 | -0.41172817 |
| NSC 2785 | Null | 0.00313644776247642 | 0.69134536 |
| NSC 327182 | L-Glutamic acid, N-[4-[[(2-amino-1,4-dihydro-4-oxo-6-quinazolinyl)methyl]-2-propynylamino]benzoyl]- | 0.00313644776247642 | -0.22100287 |
| NSC 670036 | Null | 0.00313644776247642 | -0.17944288 |
| NSC 641379 | Null | 0.00397405528023193 | -0.068231692 |
| NSC 642009 | Butanedioic acid, 2-[[2-[(3-chloro-1,4-dihydro-1,4-dioxo- 2-naphthalenyl)amino]1,2-dioxo]ethyl]-3-oxo-, dimethyl ester | 0.00397405528023193 | 0.50933865 |
| NSC 708046 | Null | 0.00397405528023193 | -0.38930735 |
| NSC 709362 | Acetamide, N,N'-(1,5-pentanediyl)bis[2-(1,3,5,11a-tetrahydro- 5-oxopyrrolo[2,1-c][1,4]benzodiazepin-2-ylidene)- | 0.00397405528023193 | -0.30652841 |